# Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

> **NCT07436793** · PHASE2 · NOT_YET_RECRUITING · sponsor: **New Mexico Cancer Research Alliance** · enrollment: 140 (estimated)

## Conditions studied

- Endometrial Endometrioid Adenocarcinoma
- Endometrial Hyperplasia

## Interventions

- **PROCEDURE:** Biopsy Procedure
- **PROCEDURE:** Curettage Procedure
- **PROCEDURE:** Hysterectomy
- **DRUG:** Megestrol Acetate
- **DRUG:** Progesterone Only Hormone Replacement Therapy

## Key facts

- **NCT ID:** NCT07436793
- **Lead sponsor:** New Mexico Cancer Research Alliance
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2030-06-30
- **Final completion:** 2031-06-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07436793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07436793, "Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07436793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*